Stereoselective actions of S-nitrosocysteine in central nervous system of conscious rats. Am. J. PhysioZ. 272 (Heart Circ. PhysioZ. 41): H2361-H2368, 1997. -This study examined whether the stereoselective actions of S-nitrosocysteine (SNC) in the central nervous system involves the activation of stereoselective SNC recognition sites. We examined the effects produced by intracerebroventricular injection of the L-and D-isomers of SNC (I,-and D-SNC) on mean arterial blood pressure, heart rate, and vascular resistances in conscious rats. We also examined the hemodynamic effects produced by intracerebroventricular injections of 1) L-cystine, the major non-nitric oxide (NO) decomposition product of I,-SNC, 2) the parent thiols L-and D-cysteine, and 3) the bulky S-nitrosothiol L-SNOG decomposed to similar amounts of NO as L-and D-SNC. These results suggest that SNC may activate stereoselective SNC recognition sites on brain neurons and that S-nitrosothiols of substantially different structure do not stimulate these sites. These recognition sites may be stereoselective membrane-bound receptors for which L-SNC is the unique ligand.
actions of S-nitrosocysteine (SNC) in the central nervous system involves the activation of stereoselective SNC recognition sites. We examined the effects produced by intracerebroventricular injection of the L-and D-isomers of SNC (I,-and D-SNC) on mean arterial blood pressure, heart rate, and vascular resistances in conscious rats. We also examined the hemodynamic effects produced by intracerebroventricular injections of 1) L-cystine, the major non-nitric oxide (NO) decomposition product of I,-SNC, 2) the parent thiols L-and D-cysteine, and 3) the bulky S-nitrosothiol L-S-nitroso-y-glutamylcysteinylglycine [L-S-nitrosoglutathione, (L-SNOG)]. Finally, we examined the decomposition of L- and D-SNC and L-SNOG to NO on their addition to brain homogenates.
The intracerebroventricular injection of L-SNC (250-1,000 n mol) produced falls in mean arterial pressure, increases in heart rate, and a dose-dependent pattern of changes in hindquarter, renal, and mesenteric vascular resistances. The intracerebroventricular injections of D-SNC, Lcystine, and L-SNOG produced only minor effects. The intracerebroventricular injection of L-cysteine produced pressor responses and tachycardia, whereas D-cysteine was inactive.
L-and D-SNC decomposed equally to NO on addition to brain homogenates.
L-SNOG decomposed to similar amounts of NO as L-and D-SNC. These results suggest that SNC may activate stereoselective SNC recognition sites on brain neurons and that S-nitrosothiols of substantially different structure do not stimulate these sites. These recognition sites may be stereoselective membrane-bound receptors for which L-SNC is the unique ligand.
SNC in the central nervous system (CNS) may be due to its ability to nitrosate amino acids within membrane proteins, including those within receptor-operated ion channels (13, 17, 23, 24) .
At present, the possibility that SNC may exert its effects in the CNS via the activation of membranebound receptors that specifically recognize this and structurally similar S-nitrosothiols (12) has not been addressed. One approach to define the possible existence of these receptors is to compare the biological potencies of the L-and D-isomers of SNC (L-SNC and D-SNC). For most receptors, the stereoisomeric configuration of the agonist is a critical determinant of binding or agonist potency at the receptor (25). Consequently, differences in the biological potencies of the L-and D-isomers of SNC would suggest the presence of stereoselective S-nitrosothiol recognition sites, especially if it could be established that the stereoisomers decompose equally to NO. In support of this possibility, we have recently provided evidence that such SNC recognition sites may exist on the vascular smooth muscle of resistance arteries in the rat (4).
S-nitrosothiols;
stereoisomers; nitric oxide; brain; hemodynamics MICROINJECTION OF S-nitrosocysteine (SNC) into the nucleus tractus solitarii (NTS) produces hypotension and bradycardia in anesthetized (14) and conscious (18) rats. Although the biological actions of this S-nitrosothiol have been ascribed to its decomposition to nitric oxide (NO) (9), microinjection of the NO donors sodium nitroprusside and glyceryl trinitrate into the NTS of anesthetized rats produced only minimal changes in mean arterial pressure (MAR) and heart rate (HR) (14). However, these studies were inconclusive, because they did not establish whether sodium nitroprusside or glyceryl trinitrite generated sufficient amounts of NO to exert biological effects in the NTS. Nonetheless, there is considerable evidence that S-nitrosothiol moieties possess biological activity that is independent of the decomposition to NO (12, 19, 21, 22) . The actions of
The aim of the present study was to provide functional evidence for the existence of stereoselective SNC recognition sites in the CNS of conscious rats. In the present study, we compared the dose-dependent effects produced by intracerebroventricular injection of L-and D-SNC on MAP, HR, and vascular resistances in conscious normotensive rats. The intracerebroventricular route of administration allows for the examination of the effects of agents on periventricular structures that regulate hemodynamic function (2, 8, 10) . We also examined the hemodynamic effects produced by the intracerebroventricular injection of L-cystine, which is the major non-NO metabolite of L-SNC (9), and the effects of intracerebroventricular injections of L-and D-cysteine on MAP and HR to examine whether the transient formation of these thiols contributes to the actions of L-and D-SNC. Because the putative stereoselective SNC recognition site may not neccesarily recognize S-nitrosothiols that have substantially different structures from SNC, we also examined the effects of the more bulky L-S-nitrosothiol L-S-nitroso-y-glutamylcysteinylglycine [L-S-nitrosoglutathione (L-SNOG)]. To determine whether possible differences in the biological potencies of the L-and D-SNC were due to the differential decomposition of the stereoisomers to NO in cerebrospinal fluid (CSF) or their contact with neuronal membranes, we examined the decomposition of these stereoisomers and L-SNOG to NO on their addition to artificial CSF (aCSF) or to brain homogenates. and exteriorized between the scapulae. The wounds were then sutured closed. To protect the probe wires and polyethylene tubing while the animals were allowed unrestricted movement during recovery and experimental testing, the free ends of the catheters and Doppler leads were led through a stainless steel skin button-spring swivel assembly that was mounted to a ring-stand clamp and suspended above the cage. The skin button was attached to the skin incision in the scapular region with stainless steel sutures. Details of the Doppler technique, including construction of the probes, the reliability of the method for the estimation of flow velocity, and quantitative determination of percent changes in resistances, have been described previously (3, 7).
In vivo protocols. After a 7-day recovery period, the animals were connected to a Beckman Dynograph coupled pressure transducer (Cobe Lab) and Doppler flowmeter (Bioengineering, University of Iowa) for the recording of HR, PP, MAP, and blood flows, respectively.
The stylus was removed from the guide cannula positioned in the cerebral ventricle, and a microinjection needle (25 gauge, 10.5 mm in total length) connected to a glass Hamilton microsyringe (1 or 5 ~1) via tubing (PE-10) was then inserted into the guide cannula. The syringe, tubing, and needle were filled with solutions of the test compounds.
After the rats had been allowed several minutes to stabilize, the intracerebroventricular injections (0.5-2 ~1) of the test compounds (250-1,000 nmol) were made. In eight rats, the effects of these doses of L-and D-SNC and vehicle (methanol) were examined over a 2-day period to minimize the effects of the injected volumes on the rats. The 1 M solutions of L-and D-SNC (and L-SNOG) were diluted to 0.5 M in methanol to allow for the 0.5-to 2.0~~1 volumes of injectate to deliver 250-1,000 nmol. The rats received a similar dose of L-and D-SNC at each experimental time. The hemodynamic effects of similar doses of L-cystine (250-1,000 nmol, n = 5) and L-SNOG (250-1,000 nmol, n = 5) were examined in separate groups of rats. In addition, the effects of L-and D-cysteine (250-1,000 nmol) on MAP and HR were examined in another group of rats (n = 5).
Relative decomposition of L-and D-SNC and L-SNOG to NO. A separate group of Sprague-Dawley rats (250-350 g, n = 12) was anesthetized with acepromazine maleate (12 mg/kg ip) and ketamine (120 mg/kg ip). The chest was opened, the rats were perfused transcardially with ice-cold 0.1 M phosphate-buffered saline (PBS; pH 7.4), and the brains were removed and placed in 5 ml of PBS. The brains were then homogenized and centrifuged, and the pellet was collected. Ten-microliter volumes of methanol containing 625-5,000 nmol of L-or D-SNC or L-SNOG were injected into sealed wells of 12-well plates (Corning Glass Works, Corning, NY) containing 90 ~1 of aCSF alone or 90 ~1 of aCSF plus 100 mg of the brain homogenate.
The NO released from the S-nitrosothiols was carried to the NO detector by a stream of N2 gas. The initial concentrations of L-and D-SNC and L-SNOG in the wells were 6.25-50 mM. These concentrations were chosen on the basis that the injection of 250-1,000 nmol of the Snitrosothiols would reach peak concentrations of 12.5-50 mM in the CSF, which has a volume of --20 ~1. The NO released by the S-nitrosothiols was measured using an NO analyzer (model 2108, Dasibi, Glendale, CA), as described previously (21). The analyzer was initially calibrated using known concentrations of NO. The NO released by the S-nitrosothiols on addition to aCSF or the brain homogenates was carried in a stream of Nz gas under vacuum to the chemiluminescence NO analyzer. The initial rates of appearance of NO and the total amounts of headspace NO were recorded. The NO was recorded from three individual experiments (3 replicates per experiment). The test solutions were dissolved in methanol. The stock and test solutions of L-and D-SNC were routinely examined spectrophometrically (2 1) to ensure that the concentrations of the stereoisomers were identical.
Statistical analysis. The data are represented as the means 2 SE. The single SE values displayed on each of the dose-response curves in Fig. 4 were determined by the formula SE = (EMS/nYh, where EMS is the error mean square term from the analysis of variance (ANOVA) and n is the number of rats per group (28). The data were analyzed by repeated-measures ANOVA (28) followed by Student's modified t-test with the Bonferroni correction for multiple comparisons between means using the EMS terms from the ANOVA (27).
RESULTS
Resting hemodynamic variables. A summary of the resting hemodynamic variables in the four groups of conscious rats used in this study is shown in Table 1 . There were no differences between groups in these parameters (P > 0.05 for all comparisons). Hemody D-SNC did not affect any of these parameters. The 1,000 nmol dose of L-SNC produced falls in MAP and tachycardia that were associated with initial increases produced a fall in MAP that was accompanied by a in HQF, RF, and MF, such that there were significant tachycardia. The fall in MAP was associated with a fall reductions in resistance in the three vascular beds. in HQF, a minor fall in RF, and an increase in MF. The Subsequently, the HQF and RF returned toward prein-500 nmol dose of D-SNC did not affect any of these jection levels, such that there were no significant hemodynamic parameters. The 1,000 nmol dose of changes in resistance. However, a pronounced and L-SNC produced a fall in MAP that was accompanied by sustained decrease in MF occurred, such that there was tachycardia. The falls in MAP were associated with a significant vasoconstriction in the mesenteric bed. pronounced increases in HQF, minor changes in RF, The 1,000 nmol dose of D-SNC produced a minor and biphasic changes in MF, consisting of an initial rise reduction in MAR, which was significantly smaller than in followed by a pronounced fall in flow. The 1,000 nmol that produced by this dose of L-SNC, a minor but dose of D-SNC produced a minor fall in MAP that was significant increase in MF, and a decrease in MR. The associated with a minor fall in HQF, no change in RF, intracerebroventricular injection of methanol (0.5-2.0 and a minor increase in MF.
~1, n = 13) did not produce significant changes in any of -+----- L-SNC.
the hemodynamic variables (P > 0.05 for all comparisons). For example, the effects produced by the intracerebroventricular injections of methanol (2.0 ~1) were +4 + 5% MAP, +7 t 7% HR, -3 t 6% HQR, +5 t 4% RR,and +8 t 6% MR.
Hemodynamic effects of intracerebroventricular injections of L-SNOG, L-and D-cysteine, and L-cystine. Typical examples of the hemodynamic effects produced by the injection of 1,000 nmol L-SNC, L-SNOG, or L-cystine in a conscious rat are shown in Fig. 3 . L-SNC produced pronounced changes in each of the hemodynamic parameters, whereas L-SNOG and L-cysteine were without effect. A summary of the hemodynamic effects produced by the intracerebroventricular injection of L-SNOG (2504,000 nmol) is shown in Table 2 . There were no effects of intracerebroventricular L-SNOG on any of these hemodynamic variables. A summary of the hemodynamic effects produced by the intracerebroventricular injection of L-cystine (250-1,000 nmol) is shown in Table 3 . The intracerebroventricular injection of these doses of L-cystine did not alter these hemodynamic parameters. A summary of the effects of L-and D-cysteine (250-1,000 nmol) on MAP and HR are summarized in Table 4 . The lower doses of L-cysteine did not affect these parameters. The 1,000 nmol dose of L-cysteine produced relatively minor but significant (P > 0.05) increases in these parameters. These doses of D-CySteine did not affect MAP or HR.
Relative decomposition of L-and D-SNC and L-SNOG to NO. The total headspace NO detected after the application of L-or D-SNC or L-SNOG to aCSF or brain homogenates in aCSF is summarized in Fig. 4 . The addition of the S-nitrosothiols to aCSF or to brain homogenate s resulted in the concentration-dependent appearance of headspace NO. The NO was detected --within l-2 s of applying the S-nitrosothiols. The rates of appearance of NO were similar after the addition of --each of the S-nitrosothiols (data not shown). The total amounts of detectable NO (as measured over lo-15 min) represented -l-2% of the parent S-nitrosothiols. The majority of the NO was detected over the first 3 min. Each concentration of L-and D-SNC generated similar amounts of NO. More NO was observed on addition of L-and D-SNC to the brain homogenates than to aCSF. L-SNOG generated similar amounts of NO as L-and D-SNC except for the highest concentration of L-SNOG, which generated somewhat less NO.
DISCUSSION
The present study demonstrates that the intracerebroventricular injection of L-SNC produces substantially greater hemodynamic responses than D-SNC in conscious rats. This study also demonstrates that the stereoisomers of SNC decomposed equally to NO on their addition to aCSF or to brain membranes. Our membrane preparation was rel atively crude, because it contained the outer neuronal membranes and the suggest that the biological potency of SNC depends on membranes from intracellular organelles. The exterior its stereoisomeric configuration rather than to its decommembranes represent a significant proportion of the position to NO. The finding that SNOG was inactive total membrane preparation. Moreover, it is likely that despite decomposing to similar amounts of NO as the denitrosation of S-nitrosothiols would be similar on L-SNC also suggests that the actions of L-SNC are not contact with membranes from the exterior neuronal dependent on its decomposition to the free radical. membranes and the intracellular organelles. These Moreover, this finding suggests that the putative SNC experiments were done in the light, and the effects of binding sites are not activated by S-nitrosothiols of various factors (such as copper) on the decomposition of substantially different structure to SNC. L-Cystine is the S-nitrosothiols to NO were not examined. To our the major non-NO product of the decomposition of knowledge, there is no evidence that these factors L-SNC (9). The observation that the intracerebrovenwould cause one stereoisomer of SNC to decompose tricular administration of L-cystine did not affect any of more readily to NO than the other. These results the hemodynamic variables monitored in these experi- MAP. However, the magnitude of the tachycardia was -50% less than would have been expected for these falls in MAP (X,16). The hypotension produced by this dose of L-SNC was accompanied by vasodilation in the mesenteric bed only. A vasoconstriction was observed in the hindquarter bed, whereas the resistance did not change within the renal vasculature.
Clearly, the vasoconstriction in the hindquarter bed would limit the expression of the hypotension. We have preliminary evidence that intravenous injection of the muscarinic antagonist methylatropine (500 pg/kg iv, n = 3) reduces the fall in MAP produced by the intracerebroventricular injection of 500 nmol L-SNC by 42 t 7% (P < 0.05). These findings suggest that the hypotensive effects of L-SNC may involve a vagally mediated reduction in cardiac output as well as the vasodilation in the mesenteric bed. The L-SNC-mediated activation of cardiovagal activity would also explain why the magnitude of the tachycardia is less than would be expected for the fall in MAP produced by this dose of L-SNC. The intracerebroventricular injection of the 1,000 nmol dose of L-SNC produced a similar fall in MAP as the lower dose of this S-nitrosothiol. In addition, the tachycardia accompanying the fall in MAP produced by the 1,000 nmol dose was similar in magnitude to that which occurred in response to the 500 nmol dose of L-SNC. However, the changes in vascular resistances produced by the 1,000 nmol dose of L-SNC were substantially different from those produced by the lower dose. For example, the 1,000 nmol dose of L-SNC produced a pronounced vasodilation in the hindquarter bed as opposed to the vasoconstriction produced by the 500 nmol dose of this S-nitrosothiol.
This suggests that the higher dose of L-SNC acts at sites that reduce autonomic outflow to the hindquarters and that these effects dominate the vasoconstrictor effects produced by the lower concentration of this compound. An alternative explanation is that the localization of these SNC recognition sites on neurons plays an important role in determining the effects of L-SNC on neurotransmission. For example, the lower concentration of L-SNC may activate a particular neuron by stimulating highaffinity SNC receptor sites on the soma of these neurons. In contrast, the higher concentrations of L-SNC may act on low-affinity receptors on nerve terminals, which results in the blockade of neurotransmitter release. The higher dose of L-SNC also produced a minor vasodilation in the renal bed that was not produced by the lower concentration of the S-nitrosothiol. Moreover, although 500 and 1,000 nmol L-SNC produced a pronounced vasodilation in the mesenteric bed, the vasodilation produced by the 1,000 nmol dose was followed by a marked vasoconstriction. These results strongly suggest that L-SNC is capable of activating both vasoconstrictor and vasodilator pathways. The precise sites at which L-SNC exerts its effects cannot be determined from the present experiments.
It is possible that the effects of SNC involve actions on neurons surrounding the lateral ventricles. However, it is also possible that the predominant effects of SNC may be
